Dual-action biotherapeutics
PHIOGEN develops biotherapeutics that eliminate bacterial pathogens and stimulate protective immunity.
Source: LinkedIn company description · Retrieved October 13, 2026
PHIOGEN is developing immunizing therapeutics that use immunomodulation to eliminate bacterial infections.
The company’s proprietary platform integrates advanced screening, human-relevant models, and evolutionary selection. PHIOGEN is a spin-out from Baylor College of Medicine and operates from a dedicated lab at Helix Park within the Texas Medical Center.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
PHIOGEN develops biotherapeutics that eliminate bacterial pathogens and stimulate protective immunity.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.